NasdaqGS - Nasdaq Real Time Price USD
Allakos Inc. (ALLK)
0.3266
+0.0009
+(0.28%)
As of 1:30:10 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-93,624
-93,624
-116,480
-279,971
-207,853
Investing Cash Flow
44,760
44,760
93,175
71,681
143,238
Financing Cash Flow
177
177
2,528
141,882
10,260
End Cash Position
19,225
19,225
67,912
88,689
155,097
Capital Expenditure
-119
-119
-592
-8,333
-33,221
Issuance of Capital Stock
--
--
990
140,591
--
Free Cash Flow
-93,743
-93,743
-117,072
-288,304
-241,074
12/31/2021 - 7/19/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MRSN Mersana Therapeutics, Inc.
0.3851
-1.26%
APLT Applied Therapeutics, Inc.
0.4158
+12.38%
CLRB Cellectar Biosciences, Inc.
0.3052
-2.31%
RLMD Relmada Therapeutics, Inc.
0.7208
+4.46%
LYRA Lyra Therapeutics, Inc.
0.0955
+3.14%
TSBX Turnstone Biologics Corp.
0.3074
-3.30%
NKGN NKGen Biotech, Inc.
0.1223
0.00%
BCAB BioAtla, Inc.
0.4302
+13.00%
VINC Vincerx Pharma, Inc. Common Stock
0.2750
+7.34%
TSVT 2seventy bio, Inc.
4.9850
-0.10%